RBR-2vd7nb招募中未知
Iron deficiency anemia in oncological patient: proposal for the implementation of a teatment protocol
niversidade Ceuma0 个研究点开始时间: 2019年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 —（—）
入选标准
- •Patients 18 years of age or older; diagnosis of solid malignancies detected in an anatomopathological examination; presenting hemoglobin levels below 12 g / dl in females or 13 g / dl in males
排除标准
- •Pregnant patients; in palliative care; with previous history of hypersensitivity to any of the iron formulations of this study; lack of adequate venous access to the infusion of the drug; refusal to continue the indicated supplementation; worsening of the oncological condition that compromises the response to treatment.
研究者
相似试验
尚未招募
不适用
To find the number of cancer patients having lower than normal healthy red blood cell due to low iron in body, and how this affects their treatmentCTRI/2022/06/043104Dr Malini Mohan
已完成
不适用
Impact and Evaluation of the Management of Iron Deficiency With or Without Anemia in Patients With CancerIron Deficiency AnemiaNCT03625661Institut Cancerologie de l'Ouest257
已完成
不适用
Prospective Evaluation of Iron Status in Cancer Patients Beginning ChemotherapyCancerNCT01968304Centre Antoine Lacassagne480
进行中（未招募）
1 期
A study to investigate the efficacy and safety of Injectafer® (ferric carboxymaltose injection) in anemia due to cancer and chemotherapycancer- and chemotherapy-related anemiaMedDRA version: 20.0Level: LLTClassification code 10002272Term: AnemiaSystem Organ Class: 100000004851EUCTR2016-002021-11-BGuitpold Pharmaceuticals, Inc.222
进行中（未招募）
1 期
A study to investigate the efficacy and safety of Injectafer® (ferric carboxymaltose injection) in anemia due to cancer and chemotherapycancer- and chemotherapy-related anemiaMedDRA version: 20.0Level: LLTClassification code 10002272Term: AnemiaSystem Organ Class: 100000004851EUCTR2016-002021-11-PLuitpold Pharmaceuticals, Inc.222